Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003821886 | SCV004627424 | pathogenic | not provided | 2023-07-09 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DUOX2-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs774830832, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Phe999Leufs*26) in the DUOX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOX2 are known to be pathogenic (PMID: 12110737, 18765513, 21565790, 24423310, 24735383). |
Gene |
RCV003821886 | SCV005331961 | uncertain significance | not provided | 2024-03-23 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |